ATTRACT essentially found that, really, it's the people with iliofemoral deep vein thrombosis (DVT) who are the ones most likely to benefit and that, in fact, quality of life was improved in the iliofemoral patients. And so that certainly suggests that we're barking up the right tree with the C-TRACT Trial.—Suresh Vedantham, MD, FSIRHot on the heels of the ATTRACT Trial results comes another exciting new trial on post-thrombotic syndrome (PTS): Chronic Venous Thrombosis: Relief with Adjunctive Catheter-directed Therapy (C-TRACT). According to private practice interventional radiologist Mary Costantino, MD, “I’m thrilled that people are researching these clinical questions, and it’s incredibly pertinent to those of us in non-university settings who are trying on a daily basis to do the right."Warren Krackov, MD, and Jaimin Shah, MD, talk with Principal Investigator Suresh Vedantham, MD, FSIR, on the importance of such research efforts, the potential for C-TRACT to help your patients, and how you can get them enrolled in the study.Learn more about C-TRACT.Contact us with your ideas and questions, or read more about about interventional radiology in IR Quarterly magazine or SIR's Patient Center.(c) Society of Interventional Radiology.Support the show